Comprehensive Characterization of the DNA Amplification at 13q34 in Human Breast Cancer Reveals TFDP1 and CUL4A as Likely Candidate Target Genes

Breast Cancer Research - United Kingdom
doi 10.1186/bcr2456
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Recurrent Amplification at 13q34 Targets at CUL4A, IRS2, and TFDP1 as an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma

PLoS ONE
Multidisciplinary
2015English

Analysis of DNA Repair-Related Genes in Breast Cancer Reveals CUL4A Ubiquitin Ligase as a Novel Biomarker of Trabectedin Response

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Identification of New Candidate Therapeutic Target Genes in Triple-Negative Breast Cancer

Genes and Cancer
Cancer ResearchGenetics
2012English

Assessment of Palindromes as Platforms for DNA Amplification in Breast Cancer

Genome Research
Genetics
2011English

Intersectin 1 (ITSN1) Identified by Comprehensive Bioinformatic Analysis and Experimental Validation as a Key Candidate Biological Target in Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Integrative Bioinformatics Analysis Reveals miR-494 and Its Target Genes as Predictive Biomarkers of Trastuzumab-Resistant Breast Cancer

Journal of the Egyptian National Cancer Institute
2020English

CUL4A Ubiquitin Ligase: A Promising Drug Target for Cancer and Other Human Diseases

Open Biology
BiochemistryImmunologyGeneticsMolecular BiologyNeuroscience
2014English

Comprehensive Analysis of lncRNAs Reveals Candidate Prognostic Biomarkers in Multiple Cancer Types

2019English

Massively Parallel Sequencing of Phyllodes Tumours of the Breast Reveals Actionable Mutations, andTERTpromoter Hotspot Mutations andTERTgene Amplification as Likely Drivers of Progression

Journal of Pathology
Forensic MedicinePathology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy